The estimated Net Worth of Dana Pizzuti is at least $2.97 Million dollars as of 3 July 2024. Dana Pizzuti owns over 14,375 units of Crinetics Pharmaceuticals Inc stock worth over $2,175,833 and over the last 2 years Dana sold CRNX stock worth over $797,445.
Dana has made over 7 trades of the Crinetics Pharmaceuticals Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently Dana exercised 14,375 units of CRNX stock worth $242,794 on 3 July 2024.
The largest trade Dana's ever made was selling 15,089 units of Crinetics Pharmaceuticals Inc stock on 20 March 2024 worth over $664,821. On average, Dana trades about 7,774 units every 42 days since 2022. As of 3 July 2024 Dana still owns at least 42,882 units of Crinetics Pharmaceuticals Inc stock.
You can see the complete history of Dana Pizzuti stock trades at the bottom of the page.
Dana's mailing address filed with the SEC is C/O CRINETICS PHARMACEUTICALS, INC., 6055 LUSK BOULEVARD, SAN DIEGO, CA, 92121.
Over the last 6 years, insiders at Crinetics Pharmaceuticals Inc have traded over $52,514,606 worth of Crinetics Pharmaceuticals Inc stock and bought 3,613,259 units worth $62,800,483 . The most active insiders traders include Advisors Llcperceptive Life..., Jack Nielsen, and Capital Viii, Llc Vivo Capi.... On average, Crinetics Pharmaceuticals Inc executives and independent directors trade stock every 20 days with the average trade being worth of $3,116,248. The most recent stock trade was executed by Stephen F. Betz on 26 August 2024, trading 3,000 units of CRNX stock currently worth $159,570.
neuropeptide receptor targeted therapeutics for the treatment of endocrine diseases and cancers. we are driven by a passion for drug-hunting and tempered by a post-recession startup culture. our goal is to create new therapeutics that can make a meaningful difference in the lives of our patients.
Crinetics Pharmaceuticals Inc executives and other stock owners filed with the SEC include: